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Background: Meta-analysis has been widely used in genetic association studies to increase sample size and to improve
power, both in the context of single-variant analysis, as well as for gene-based tests. Meta-analysis approaches for
haplotype analysis have not been extensively developed and used, and have not been compared with other ways of
jointly analysing multiple genetic variants.
Methods: We propose a novel meta-analysis approach for a gene-based haplotype association test, and compare it
with an existing meta-analysis approach of the sequence kernel association test (SKAT), using the unrelated samples
and family samples of the Genetic Analysis Workshop 19 data sets. We performed association tests with diastolic blood
pressure and restricted our analyses to all variants in exonic regions on all odd chromosomes.
Results: Meta-analysis of haplotype results and SKAT identified different genes. The most significantly associated gene
identified by SKAT was the ALCAM gene on chromosome 3 with a p value of 7.0 × 10− 5. Two of the most associated
genes identified by the haplotype method were FPGT (p = 6.7 × 10− 8) on chromosome 1 and SPARC (p = 3.3 × 10− 7)
on chromosome 5. Both genes were previously implicated in blood pressure regulation and hypertension.
Conclusion: We compared two meta-analysis approaches to jointly analyze multiple variants: SKAT and haplotype tests.
The difference in observed results may be because the haplotype method considered all observed haplotypes, whereas
SKAT weighted variants inversely to their minor allele frequency, masking the effects of common variants. The two
approaches identified different top genes, and appear to be complementary.Background
In recent years, genome-wide association studies (GWAS)
have unearthed a large number of single-nucleotide vari-
ants (SNVs) associated with many diseases [1]. Most asso-
ciated variants have been common, with a minor allele
frequency (MAF) of greater than 5 % and have been iden-
tified using a 1-SNV-at-a-time approach, where asso-
ciation with each SNV is evaluated separately, ignoring* Correspondence: vafisher@bu.edu
†Equal contributors
Department of Biostatistics, Boston University School of Public Health,
Boston, MA 02118, USA
© 2016 The Author(s). Open Access This artic
International License (http://creativecommons
reproduction in any medium, provided you g
the Creative Commons license, and indicate if
(http://creativecommons.org/publicdomain/zelinkage disequilibrium (LD) between SNVs. A large num-
ber of associated variants were discovered only after com-
bining GWAS results from multiple cohorts using meta-
analysis approaches. To better focus on rare variants,
methods to jointly analyse variants have been developed
with meta-analysis extensions to combine results from
multiple cohorts [2, 3]. These methods include burden
tests, where association between a trait and the number of
rare alleles a person carries is evaluated, and the sequence
kernel association test (SKAT), which aggregates the evi-
dence for association over multiple SNVs allowing for dif-
ferent direction of effects [4]. All of these approachesle is distributed under the terms of the Creative Commons Attribution 4.0
.org/licenses/by/4.0/), which permits unrestricted use, distribution, and
ive appropriate credit to the original author(s) and the source, provide a link to
changes were made. The Creative Commons Public Domain Dedication waiver
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Fig. 1 Number of SNVs with a MAF <5 % for each gene grouping
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alleles inherited together influence the trait. Even though
single cohort approaches for haplotype analysis have been
developed [5, 6], meta-analysis of haplotype results re-
mains challenging because of the possibility of cohort-
specific haplotype structure.
In this paper, we compare two multi-SNV analysis ap-
proaches applied to the Genetic Analysis Workshop 19
(GAW19) data, using both family and unrelated data.
We use meta-analysis to combine the results from SKAT
and haplotype analysis, using a novel approach for meta-
analysis of haplotype results developed by our group.
We apply these approaches to subsets of SNVs defined
by gene location.
Methods
For all analyses considered, SNVs are grouped by gene loca-
tion, and variants within each gene are tested for association
with the phenotype of interest. Gene-based groupings were
identified from the hg19 reference genome with the ANNO-
VAR (Annotate Variation) software [7]. From the family data
set, we analyzed 464 individuals with sequence data available
and 407 individuals from the unrelated data set.
We performed joint analysis of rare variants to assess
association with diastolic blood pressure (DBP) adjusted
for baseline age and sex. We adjusted DBP values for
the use of blood pressure–lowering medication by add-
ing ten to the observed DBP for all subjects reported to
be on medication [8].
SKAT analyses were conducted with the RAREMETAL
software [3]. Genome-wide single-variant association tests
are calculated for family and unrelated samples separately
with the RAREMETALWORKER software. The results
were combined to calculate fixed-effect meta-analytic tests
of association between the phenotype and groups of vari-
ants. The haplotype association test was implemented in
R. Rare haplotypes (<0.5 %) were collapsed to ensure com-
putational stability. To evaluate type 1 error rate of the
haplotype analysis method, we analyzed genes on chromo-
some 17 from all 200 simulation replicates. We excluded
genes located within 1 Mb of SNVs simulated to have an
effect on any of the blood pressure traits.
Sequence kernel association test
The SKAT method [4] is based on a regression model of
phenotype as a function of covariates and genotypes at all
loci within a region. Familial relatedness was incorporated
at the cohort level by means of the expected kinship
matrix calculated from the pedigree structure. For a gene-
based group containing p variants, with effect parameters
β1,⋯, βp, the genotype-phenotype association is evaluated
with the null hypothesis H0: β1 = β2 =⋯ = βp = 0. Specific-
ally, under the assumption that each βj is distributed with
mean zero and variance wjτ where wj is a specified weightfor SNV j, this is equivalent to the null hypothesis τ = 0,
which is assessed by means of a variance components
score test. In accordance with Wu et al. [4], weights are of
the form wj = Beta(MAFj; 1, 25)
2 where the Beta distribu-
tion is evaluated at the MAF of that variant. This weights
the rarest variants most heavily and smoothly reduces the
weights of common variants, reflecting the assumption
that natural selection against strong causal SNVs will re-
sult in lower frequency in the population. Several authors
have developed approaches for meta-analysis of SKAT re-
sults, enabling the combination of GAW19 related and
unrelated samples [2, 3].
Haplotype association test
We developed a novel approach to test the association
between haplotype structure and phenotype so as to bet-
ter understand the genetic architecture of each region
and its influence on DBP. We incorporated family struc-
ture into the model proposed by Zaykin et al. [6] so that
our approach is applicable to both unrelated and related
samples. For K observed haplotypes, we model the
phenotype at the cohort level as
Y ¼ Xγþ β1h1 þ…þ βKhK þ bþ ε
where Y is the trait (DBP at baseline), X are covariates such
as age and sex with no intercept, hk is the dosage of the k
th
haplotype out of K observed haplotypes, b~N(0, 2σ2Σkin) is
a random effect vector that accounts for the familial cor-
relation, Σkin is the expected kinship matrix derived from
Fig. 2 Association results for all odd chromosomes: the upper half represents SKAT -log10(p value); the lower half shows log10(p value) for the
haplotype method
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tation, haplotype dosages are estimated from genotypes
using an expectation–maximization algorithm (R Package
haplo.stats [5]) ignoring familial information but exploiting
the LD among genetic variants. We use a weighted least-
squares method [9] to meta-analyze the beta coefficients
for the K′ haplotypes observed in one or more cohorts.
After meta-analysis, we test the global null hypothesis that
all haplotype effects are equal (ie, H0: β1 =⋯ = βK '). A
Wald test with df = K′ − 1 is implemented to test the
reparameterized null hypothesis H0: γ2 =⋯ = γK ' = 0
where γi = βi − βc and the subscript “C” refers to one of












Both methods require specification of SNV sets for com-
bined analysis. We restrict our attention to variants in
exonic regions, and group SNVs by genes. We consid-
ered 8806 genes across the odd-numbered chromo-
somes. Of these, 135 contained only one SNV, while the
obscurin protein-coding (OBSCN) gene on chromosome
1 had the maximum of 1054 SNVs in its exonic regions.
Figure 1 shows the distribution of SNVs per gene.
Type I error evaluation of the novel haplotype associ-
ation method revealed an inflated type I error rate for
genes with more than 14 haplotypes, but not for genes











Table 2 Top 10 signals for gene-based haplotype analysis
Gene Chromosome Position # SNVs # Haplotype Haplotype p value SKAT p value
ADSS 1 244572897 3 3 5.9E-08 0.43
FPGT 1 74670081 5 5 6.7E-08 1.4E-03
MYL10 7 101256771 4 6 1.7E-07 2.1E-03
FGR 1 27939439 2 3 1.8E-07 0.12
KIF2A 5 61642994 5 3 2.0E-07 0.91
SPARC 5 151043147 3 4 3.3E-07 8.5E-02
CYP2A13 19 41594384 8 6 3.4E-07 0.32
PKLR 1 155260382 3 4 3.7E-07 1.2E-03
CADM4 19 44127515 2 3 4.2E-07 4.7E-02
ZNF529 19 37037771 7 7 5.7E-07 0.22
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in Fig. 2 we report only results from genes with fewer than
14 haplotypes, after collapsing rare haplotypes together.
The most significant gene-based SKAT result was
found in the activated leukocyte cell adhesion molecule
(ALCAM) gene on chromosome 3; Table 1 lists the top
ten SKAT association results. This gene codes for an im-
munoglobulin protein that is expressed in neural and
epithelial cells [10]. The association p value with the set
of 28 ALCAM SNVs was 7.0 × 10−5. However, none of
the SKAT gene-based tests reached the genome-wide
significance threshold, with Bonferroni correction for
the 8806 genes tested (5.7 × 10−6).
Two of the most significant genes found to be asso-
ciated with DBP by the haplotype method were
fucose-1-phosphate guanylyltransferase (FPGT) on
chromosome 1 and secreted protein, acidic, cysteine-
rich (SPARC) on chromosome 5. Both genes (pFPGT =
6.7 × 10− 8; pSPARC = 3.3 × 10
− 7) reached the genome-wide
significance using Bonferoni correction. Table 2 lists the
top ten haplotype association results.Discussion
The top gene association from the SKAT analysis,
ALCAM, has been identified in a quantitative trait locus
for systolic blood pressure in previous literature [11] and
has shown differential gene expression in rats with
hypertension [12].
The meta-analysis of haplotype results identified as its
second strongest signal the gene FPGT, a gene in LD with
a single nucleotide polymorphism (SNP) previously re-
ported to be associated (p = 7.2 × 10− 5) with DBP in the
lymphoblastoid cell line [13]. Our haplotype methods de-
tected a much stronger association between FPGT and
DBP (p = 6.7 × 10− 8). This stronger signal might be the re-
sult of the joint impact of all the five SNVs located in this
gene. The sixth most significant gene identified by the
haplotype approach, SPARC, contains three variants andwas previously shown to be associated with cardiac dys-
function [14].
Conclusions
We performed gene-based multi-SNV analyses to iden-
tify regions of the genome associated with DBP. While
we observed some consistencies between the SKAT and
haplotype analyses, the haplotype analysis revealed mul-
tiple genome-wide significant results, some in genes that
have been previously implicated in blood pressure regu-
lation. Further investigation in a larger number of partic-
ipants is needed to confirm the novel associations
identified in this report.
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